Web-Michael_Hoffman-6982-Edit- (Zoom)

Michael Hoffman Senior Advisor

Michael joined Santé Ventures in 2019 as a Senior Advisor. He also currently serves as the Chairman of Hoffman Ventures Limited, Chairman of the International Board of Advisors at The University of Texas at Austin, Member of Advisory Board at All Advisory Board of the Columbia University School of International and Public Affairs, Member of the Chancellor’s Council of the University of Texas System, Board Member of the Guildhall School of Music and Drama, Chairman of the Trustees of Richmond University and Chairman of The American Academy in Berlin. In addition to the roles above, he is also a Trustee of George Washington University, Director of the United States-Spain Council, the Salzburg Seminar and as a Member of the New York Council on Foreign Relations. Michael continues to serve on the Boards of a number of performing arts organizations such as Almeida Theatre in London. He also serves as the Chairman of The Museum of London Development Board; Chairman of London Archaeology, Chairman of The Philharmonia Trust, a Member of The British Library Campaign Board; and as a Trustee of The Philharmonia Orchestra. He serves as a Member of Council of Advisor at RAND Europe.

Prior to joining Santé Ventures, he co-founded Palamon Capital Partners, LP in 1999, where he served as chairman until 2015 as well as Managing Partner. Previously, he served as a Partner of London office at Warburg Pincus LLC for 11 years, starting in 1987. Prior to joining Warburg Pincus, he had a 15-year career as a Management Consultant with McKinsey & Co, Inc., Booz Allen Hamilton Holding Corporation and Arthur D. Little, Inc.

Previous board memberships include having served on the Elliott School of International Affairs Board of Advisors, Board of Directors at WEW Group plc, The Royal Shakespeare Company, and numerous cultural and academic institutions including being a Founding Director of The Shakespeare Globe Theatre. Michael received a B.A., cum laude, from the University of Texas, an M.A. in International Economics from Columbia University and an M.B.A. from Harvard University.

News
November 18, 2019 Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
Read More
September 30, 2019 NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
Read More